Alexandria Real Estate Equities
ARE
#2076
Rank
ยฃ7.27 B
Marketcap
ยฃ41.77
Share price
3.62%
Change (1 day)
-21.09%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - P/B ratio

P/B ratio as of June 2026 : 0.4970

According to Alexandria Real Estate Equities 's latest financial reports the company has a price-to-book ratio of 3.37062.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Alexandria Real Estate Equities - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-310.4418-42.43%
2024-12-310.7674-21.2%
2023-12-310.9738-7.59%
2022-12-311.05-43.08%
2021-12-311.853.49%
2020-12-311.79-6.82%
2019-12-311.9218.48%
2018-12-311.62-16.56%
2017-12-311.9418.44%
2016-12-311.647.4%
2015-12-311.53-5.88%
2014-12-311.6242.54%
2013-12-311.14-9.07%
2012-12-311.250.55%
2011-12-311.24-7.69%
2010-12-311.3515.1%
2009-12-311.174.89%
2008-12-311.12-47.73%
2007-12-312.143.36%
2006-12-312.07-2.75%
2005-12-312.13-9.56%
2004-12-312.356.86%
2003-12-312.2032.2%
2002-12-311.66

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.53 208.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
34.5 6,848.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
21.0 4,134.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.78 1,263.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
9.98 1,908.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.84 1,075.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
36.2 7,179.07%๐Ÿ‡บ๐Ÿ‡ธ USA